Continuing Medical Education

Continuing Medical Education Videos

The Opioid Epidemic and the new Indiana Medical Licensing Board Opioid Laws

This CME webinar offered by the Prescription Drug Abuse Task Force through the Office of the Attorney General will introduce Indiana's new emergency rules for physicians which govern the prescribing of opioids for chronic pain patients as promulgated by the Indiana Medical Licensing Board. Participants will also be offered a comprehensive overview of the Indiana Prescriber Toolkit which is designed to guide all prescribers on ways to comply with these new regulations and to properly manage chronic non-terminal pain patients.

CME Information*
The Indiana State Medical Association (ISMA) designates this program for a maximum of 1.0 AMA PRA Category 1 Credits™. (to claim credit see below).  This online CME is intended for the sole and exclusive educational use of the person who registers for it. 
On December 15, 2013, the Medical Licensing Board of Indiana established emergency rules which created standards and protocols for the long-term prescribing of opioids.  Learn about these rules and information on the First Do No Harm: The Indiana Healthcare Providers Guide to the Safe, Effective Management of Chronic Non-Terminal Pain developed by the Indiana Prescription Drug Abuse Prevention Task Force’s Education Committee.
At the end of the activity, participant should be able to
• Learn more about the prescription drug abuse epidemic in Indiana
• List Indiana’s new prescribing laws
• Identify tools to help comply with these laws
If you would like to claim CME credit for this presentation, please complete the following survey.
*CME Information:
The Indiana State Medical Association (ISMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Note:  While offering the CME credit hours listed in these pages, these activities are not intended to provide extensive training in a field.
Disclosure:  In accordance with ACGME Standards for Commercial Support, educational programs sponsored by the ISMA must demonstrate balance, independence, objectivity and scientific rigor.  Prior to the activity, all faculty, authors, editors and planning committee members participating in an ISMA-sponsored activity are required to disclose to attendees any relevant financial interest or other relationship with the manufacture(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity. 


Future Events

Save the Date

 Save the Date

2014 Prescription Drug Abuse Symposium

October 16 – October 17, 2014

Westin Hotel, Downtown Indianapolis

Thursday, October 16:  ½ Day session followed by a reception featuring special guests (TBA)

Friday, October 17:  Full day program beginning at 8 am


Room blocks will be made available for Symposium attendees. If you anticipate needing a room on October 16, please email to allow us to get an estimated headcount on the number of rooms needed.

Continuing Education Credits Including:  CME, CLE, CEUs for Mental Health & Addiction Treatment Professionals, State Board of Pharmacy credits, and LETBs for Law Enforcement

2013 Indiana Prescription Drug Abuse Symposium

More than 600 professionals participated in the Indiana Attorney General's 4th Annual Prescription Drug Abuse Symposium to target strategies to more aggressively combat this issue in our state. Attendees were composed of Indiana's health professionals, law enforcement officials, state legislators and other key stakeholders.

Check out the following list of last year's presentations and presenters which includes links to presentation materials:

Brain Disease of Addiction and How to Avoid Iatrogenic RelapseJames D. Ryser, Program Manager, Pain Services at Indiana University Health

A Hidden Epidemic: Neonatal Abstinence SyndromeCarla Saunders, NNP-BC, Advanced Practice Nurse Coordinator, East Tennessee Children’s Hospital  

Prevention and ProsecutionJoseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, U.S. Drug Enforcement Administration

Monitoring: Drug Screening and INSPECT
Andrea Terrell, Ph.D., DABCC, Chief Scientific Officers, AIT Laboratories
Greg Pachmayr, INSPECT Director, Indiana Professional Licensing Agency

Treatment Program for JuvenilesGeoffrey Gaither, Magistrate, Marion County Superior Court, Juvenile Division

Collaboration and Supervision of Advanced Practice Nurses and Physician AssistantsAnne O’Brien, Associate, Krieg DeVault

Non-Pharmacologic Options for Chronic Non-Terminal Pain ManagementPalmer MacKie, M.D., Associate Professor of Clinical Medicine, Indiana University School of Medicine

Indiana Administrative Rules on Prescribing of Opioids for Chronic Pain Patients and Overview of the Rule Compliance Guide/Indiana Prescriber ToolkitDeborah McMahan, M.D., Allen County Health Dept & John McGoff, M.D., Medical Licensing Board Member, Indiana State Medical Association Trustee

Video of the 2013 Prescription Drug Abuse Symposium

Video of the 2012 Prescription Drug Abuse Symposium

Indiana State Medical Association’s recent related recorded webinars: